Iris Dorbian

New Era raises $60 mln for inaugural fund

New Era Capital Partners, a Tel Aviv-based venture firm, has closed its debut fund at $60 million. The fund will invest in Israeli social impact companies.

Fintech company Affirm lands $300 mln Series F

Affirm, a fintech company, has raised $300 million in Series F funding. Thrive Capital led the round.

Fusion Pharmaceuticals racks up $105 mln Series B

Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company, has raised $105 million in Series B financing. Varian and OrbiMed led the round with participation from other investors that included Perceptive Advisors, Pivotal bioVenture Partners, Rock Springs Capital, Healthcap, Adams Street Partners, Johnson & Johnson Innovation – JJDC Inc, TPG Biotech, Seroba Life Sciences, Genesys Capital and FACIT. In conjunction with the funding, Deepak Khuntia, senior vice president and chief medical officer at Varian, Chau Q. Khuong, a partner at OrbiMed and Heather Preston, a managing director at Pivotal bioVenture Partners, will join Fusion’s board of directors.

Cadron Capital raises $1.53 mln for $20 mln-targeted fund

Cadron Capital Partners has raised $1.53 million for its new fund, according to an SEC filing. The target is $20 million. The Arkansas-based venture firm invests in tech startups.

Segment gathers $175 mln Series D

San Francisco-based Segment, a customer data infrastructure company, has raised $175 million in Series D funding. Accel, GV and Meritech Capital led the round with participation from Thrive Capital, Y Combinator Continuity, eVentures and Sapphire Ventures.

Vertical Companies rakes in $58 mln Series A

Vertical Companies, a multi-state cannabis operator, has raised $58 million in Series A financing. The investors included Merida Capital Partner.

Belgian biotherapeutics firm AgomAb inks Series A funding

AgomAb, a Belgian biotherapeutics company, has secured 21 million euros in Series A funding. V-Bio Ventures and Advent France Biotechnology led the round with participation from Boehringer Ingelheim Venture Fund, Omnes and Pontifax.

Home-buying and selling platform Perch pulls in $220 mln

New York and Austin-based Perch, a home buying and selling platform, has secured $220 million in funding, according to a blog post on its site. FirstMark Capital led the round with participation from Accomplice and Juxtapose.

Good Dog barks away with $6.7 mln

Good Dog, a marketplace that makes it simple for people to get dogs from good sources and reputable breeders, has secured $6.7 million in funding. The investors included BoxGroup, Felicis, Slow Ventures, Fuel Capital, BarkBox and SV Angel.

byFounders collects 100 mln euros for Nordic and Baltic tech fund

byFounders, a Danish early-stage venture firm, has raised 100 million euros for its new fund, according to a Medium blog post. The fund will invest in Nordic and Baltic tech startups. The fund's investors included Danish Growth Fund, Isomer Capital, Draper Esprit and Digital Garage.